More PRNewswire
View Older Stories View Newer Stories-
Vooglam Brings Immersive Eyewear Experience to Electric Forest with Cult Vision Collection
-
Kinterra Capital Submits Proposal to Acquire 100% of New World Resources
-
IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy of Neurology (EAN)
-
Minjee Lee Wins KPMG Women's PGA Championship With a Callaway Elyte Driver, Callaway Chrome Tour X Golf Ball, and an Odyssey Ai-ONE Square 2 Square Putter
-
Risen Energy Highlights Advancements in Green Manufacturing, Sustainable Development and Corporate Responsibility in 2024 ESG Report
-
Blockchain Alliance International Launches Asia-Pacific Digital Economy Initiative in Hong Kong
-
Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers
-
Treeline Global Secures 25-Year Mandate to Deploy $6.2 Trillion Scientific Framework; Additional Strategic Systems Announced
-
EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds
-
Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes
-
Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the ISTH 2025 Congress
-
Lilly's once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials
-
Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy
-
Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes
-
Oklahoma City (OK) Mayor David Holt Elected New President of the U.S. Conference of Mayors, Policy Agenda Adopted for the Year Ahead, as Annual Meeting Concludes
-
From Cult Thriller to Real-Life Dares: The Producers of Would You Rather Launch CAJOLE -- A Platform Asking How Far You'd Go for the Right Price
-
FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance
-
Monster Energy Athletes Claim Victories and Make Action Sports History On the Final Day of X Games Osaka 2025
-
From Grit to Glory: Rockford Hosts Illinois' First IRONMAN, Cementing Its Role on the National Sports Stage
-
CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in NEJM
-
CagriSema Demonstrates Significant Weight Loss in Adults with Obesity
-
FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025
-
A. Fagundes Plumbing & Heating Inc. Celebrates National HVAC Tech Day by Investing in the Next Generation of Technicians
-
Monster Energy's Marine Cabirou Takes First Place at 2025 UCI Downhill Mountain Bike World Cup in Val Di Sole
-
ROCKIT READY TO LAUNCH STRONG 2025 SEASON
-
NICKELODEON KIDS' CHOICE AWARDS 2025 HIGHLIGHTS AND WINNERS
-
The American Legion Statement on U.S. Military Activity in Iran
-
Multiple Research Results from Innovent's General Biomedicine Pipeline to be Showcased at the ADA 85th Scientific Sessions
-
Monster Energy's Arisa Trew (Skateboarding) and Ryan Williams (BMX) Earn Dominant Victories on Day 1 of X Games Osaka 2025
-
HD Hyundai Joins Forces with U.S. Shipbuilder for Vessel Construction
-
The American Diabetes Association Announces Winners of the Innovation Challenge to Transform Diabetes Care
-
Foothill Gold Line Dedicates Four New Metro A Line Stations From Glendora to Pomona
-
Celebrity Stylist Axel Rojas Opens Hair Salon in Dallas
-
Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes
-
TEAMSTERS NURSES AT COREWELL RALLY AGAINST EMPLOYERS' ATTACKS
-
Acki Nacki Partners With Top Casters For Live Popit Games Final
-
Winners of the 27th Shanghai International Film Festival Golden Goblet Awards Revealed
-
Lilly's oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The New England Journal of Medici
-
MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA's 85th Scientific Session
-
New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine
-
New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine
-
Shokz Support 5 Pro Athletes Competing In The 2025 Western States Endurance Run
-
William Stern's Cardiff Redefines Working Capital for Small Businesses
-
MolecuLight Showcases Innovative Multimodal Imaging with Thermal Capabilities at St. Louis Wound & Vascular Symposium
-
Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association's 85th Scientific Sessions
-
TEAMSTERS NURSES AT COREWELL TO RALLY AGAINST EMPLOYERS' ATTACKS
-
DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years
-
CHAI - AI Lab Quantizes Social AI to 4-bit for +56% Increase in Throughput
-
Media Advisory (Ohio) Notice of Data Incident June 20, 2025
-
enCore Energy Announces Filing of Early Warning Report
